CIK 0001527753 · Non-accelerated filer<br>Smaller reporting company
Personalis, Inc.
Sign in to watch- Ticker
- PSNL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275411038
- Phone
- 650-752-1300
- Business address
- 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Option exercise Chief Scientific Officer acquired 25,000 shares (option exercise)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Business Officer acquired 11,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 37,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 82,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 82,500 shares (grant or award)
- 4 Open-market sale Chief Scientific Officer sold 1,000 shares at $7.84 ($7,840)
- 4/A Open-market sale Chief Scientific Officer sold 101,000 shares at $8.77 ($885,770)
- 4 Open-market sale Chief Scientific Officer sold 1,000 shares at $8.76 ($8,760)
- 4 Open-market sale Chief Scientific Officer sold 101,000 shares at $8.77 ($885,770)
- 5 Insider Annual Insider Trading Report
Page 25 of 28 · 557 filings